Breast Cancer Profiling Project, Drug Sensitivity phase II: Fixed-cell GR measures of 33 breast cell lines and PDX lines to 16 small molecule perturbagens from library plate II. Dataset 1 of 2: Normalized growth rate inhibition values - Dataset (ID:20354)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Mean Normalized Growth Rate Inhibition Value | Increased Fraction Dead |
|---|---|---|---|---|
| HCC1954 | Ulixertinib | 10.0 | 0.2848 | 0.04825 |
| MCF 10A | Ulixertinib | 0.031622777 | 0.8094 | -0.00027 |
| CAL-120 | Ulixertinib | 0.01 | 1.0428 | -0.00053 |
| CAL-120 | Ulixertinib | 0.003162278 | 0.9890 | -0.00182 |
| CAL-120 | Ulixertinib | 0.003162278 | 0.9598 | -0.00227 |
| MDA-MB-468 | Ulixertinib | 0.316227766 | 0.6580 | 0.02165 |
| CAL-120 | Ulixertinib | 0.003162278 | 1.0519 | -0.00005 |
| CAL-120 | Ulixertinib | 0.001 | 1.0114 | 0.00094 |
| CAL-120 | Ulixertinib | 0.001 | 1.0281 | -0.00355 |
| CAL-120 | Ulixertinib | 0.001 | 1.0582 | 0.00360 |
| HCC1395 | Ulixertinib | 0.001 | 1.2160 | 0.00955 |
| HCC1395 | Ulixertinib | 0.001 | 0.8694 | 0.00792 |
| HCC1395 | Ulixertinib | 0.001 | 1.0432 | -0.00495 |
| HCC1395 | Ulixertinib | 0.003162278 | 1.1011 | -0.00239 |
| HCC1395 | Ulixertinib | 0.003162278 | 0.9085 | -0.00034 |
| HCC1395 | Ulixertinib | 0.003162278 | 0.9553 | -0.00436 |
| HCC1395 | Ulixertinib | 0.01 | 0.7915 | -0.00640 |
| HCC1395 | Ulixertinib | 0.01 | 1.1853 | 0.00057 |
| HCC1395 | Ulixertinib | 0.01 | 0.8754 | 0.05397 |
| HCC1395 | Ulixertinib | 0.031622777 | 0.8394 | 0.01699 |
| HCC1395 | Ulixertinib | 0.031622777 | 0.7811 | -0.00420 |
| HCC1395 | Ulixertinib | 0.031622777 | 0.8304 | 0.02985 |
| HCC1395 | Ulixertinib | 0.1 | 0.9402 | 0.01913 |
| CAL-120 | Ulixertinib | 0.01 | 0.9859 | 0.00673 |
| HCC1395 | Ulixertinib | 0.1 | 0.7736 | 0.00546 |